SREBF1 and metabolic dysfunction-associated steatotic liver disease: 2) by regulating the expression of genes associated with fatty acid metabolism (SREBP-1c, PPARα, ACOX-1, and CPT-1) in the liver, it regulates the synthesis and oxidative decomposition of fatty acids to prevent NAFLD.